Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1987 1
1989 1
1993 1
1999 1
2000 4
2001 2
2003 4
2004 8
2005 6
2006 2
2007 9
2008 7
2009 20
2010 13
2011 33
2012 32
2013 27
2014 32
2015 31
2016 36
2017 69
2018 60
2019 35
2020 31
2021 35
2022 39
2023 39
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Filler-induced alopecia.
Park GH, Kim WI, Yang MY, Lee WK, Kim GW, Kim HS, Ko HC, Kim BS, Kim MB. Park GH, et al. Among authors: kim mb. J Dermatol. 2019 Nov;46(11):e392-e393. doi: 10.1111/1346-8138.14936. Epub 2019 Jun 5. J Dermatol. 2019. PMID: 31166028 No abstract available.
Onychophagia: detailed clinical characteristics.
Shin JO, Roh D, Son JH, Shin K, Kim HS, Ko HC, Kim BS, Kim MB. Shin JO, et al. Among authors: kim mb. Int J Dermatol. 2022 Mar;61(3):331-336. doi: 10.1111/ijd.15861. Epub 2021 Aug 20. Int J Dermatol. 2022. PMID: 34416026
Pheochromocytoma presenting as livedo reticularis.
Yun J, Bae KN, Shin K, Kim HS, Ko HC, Kim MB, Kim B. Yun J, et al. Among authors: kim mb. Eur J Dermatol. 2023 Feb 1;33(1):54-56. doi: 10.1684/ejd.2023.4419. Eur J Dermatol. 2023. PMID: 37178039 No abstract available.
Bullous Wells Syndrome Induced by Ustekinumab.
Kim Y, Bae KN, Son JH, Shin K, Kim H, Ko HC, Kim B, Kim MB. Kim Y, et al. Among authors: kim mb. Ann Dermatol. 2023 May;35(Suppl 1):S180-S181. doi: 10.5021/ad.21.225. Ann Dermatol. 2023. PMID: 37853906 Free PMC article. No abstract available.
505 results